Risk of Venous Thromboembolism in Non-Hodgkin Lymphoma patients surviving Blood or Marrow Transplantation

BACKGROUND: Patients with non-Hodgkin lymphoma (NHL) have increased risk of venous thromboembolism (VTE), particularly when receiving treatment. Blood or marrow transplantation (BMT) is recommended for relapsed/refractory NHL, and the risk of VTE after they undergo BMT is uncertain. METHODS: We surv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Gangaraju, Radhika, Chen, Yanjun, Hageman, Lindsey, Wu, Jessica, Francisco, Liton, Kung, Michelle, Ness, Emily, Parman, Mariel, Weisdorf, Daniel J., Forman, Stephen J., Arora, Mukta, Armenian, Saro H., Bhatia, Smita
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6891120/
https://ncbi.nlm.nih.gov/pubmed/31469420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32488
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars